Tcon stock news

2020-1-11 · TRACON Pharmaceuticals Inc (NASDAQ:TCON) rose 5.1% during mid-day trading on Thursday . The stock traded as high as $2.68 and last traded at $2.66, approximately 754,221 shares traded hands during trading. An increase of 6% from the average daily volume of 713,803 shares. The stock had previously closed at $2.53. TCON has been the topic […] TradingView India. View live TRACON PHARMACEUTICALS INC chart to track its stock's price action. Find market predictions, TCON financials and market news. On Friday, December 20, 2019, the Company, TRACON Pharmaceuticals, Inc., TCON stock construct a change of -2.01 percent (↓ / Loss) in a total of its share price and having its trading value $2.44, which belongs to Healthcare sector and Biotechnology industry. The company’s Market capitalization was $7.34M with the total Outstanding Shares of 3.01M.

Analyzing TRACON Pharmaceuticals (NASDAQ:TCON) stock? View TCON's stock price, price target, earnings, financials, forecast, insider trades, news, and SEC filings at MarketBeat. TRACON Pharmaceuticals, Inc. (TCON) Company Bio Tracon Pharmaceuticals develops targeted therapies for cancer, wet age-related macular degeneration and fibrotic diseases. The company was founded in 2004 and is based in San Diego, California. Securities products and services offered to self-directed investors through ST Invest, LLC. Member FINRA / SIPC.ST Invest is a wholly owned subsidiary of StockTwits, Inc. Investing in securities products involves risk, including possible loss of principal. Please read important legal disclosures. 2020-1-6 · Shares of Tracon Pharmaceuticals Inc. (TCON) were up 29% in premarket trading on Friday after the company said it would partner with two Chinese companies to develop its investigational soft tissue sarcoma therapy in North America.The partner companies are 3 D Medicines Co. Ltd. and Jiangsu Alphamab Biopharmaceuticals Co. Ltd., both privately held. TCON stock news. Tracon Pharma Shares Rally As First Patient Dosed In Cancer Trial 03:33pm, Thursday, 01'st Aug 2019. Shares of the thinly traded nanocap biotech TRACON Pharmaceuticals Inc (NASDAQ: TCON ) were rallying Thursday. What Happened Tracon, which specializes in novel therapeutics for cancer, said it has dosed the first patient in a U

View live TRACON PHARMACEUTICALS INC chart to track its stock's price action. Find market predictions, TCON financials and market news.

LG 49VL5B-B TCON board 6870C-0659A / 6871L-4672A lenses Can I zoom with the WCON or TCON lenses? - Olympus Camedia E-20N Digital Camera question Winnipeg's premier retailer of Contemporary, Modern, Tranisitional and Traditional furniture since 1973, browse online or call 1-204-774-5526. We have a huge selection of leather and fabric sofas, accent chairs and loveseats, bedroom and… Telaria released its Q4 earnings report this morning and the results sang an impressive tune. Now, the TLRA stock is climbing fast. Details inside.

See TRACON Pharmaceuticals price target based on 1 analysts offering 12 month price targets for TRACON Pharmaceuticals in the last 3 months. The average 

View TCON stock info; drug pipeline; latest news; SEC filings; articles; upcoming catalysts and more at BioPharmCatalyst.

Electric Heating Systems for domestical and industrial purposes powered by Raychem and Pentair cables. SAMM Techonology can designs the solution needed for your heating requirements.

Ahead of the release of the Groupon earnings report, investors are wary about the impact on Groupon stock. Here's what you need to know.

Technical stock forecast for TCON: Several short-term signals, along with a general good trend, are positive and we conclude that the current level may hold a 

Common Stock ($0.001 par value)

12 hours ago TRACON Pharmaceuticals Inc. (TCON) shares on Tuesday's trading session, jumped 3.70 percent to see the stock exchange hands at $2.80  TCON: Get the latest TRACON Pharmaceuticals stock price and detailed information including TCON news, historical charts and realtime prices. Get today's TRACON Pharmaceuticals Inc stock price and latest TCON news as well as TRACON Pharma real-time stock quotes, technical analysis, full  2 days ago On Friday, shares of TRACON Pharmaceuticals, Inc. (NASDAQ:TCON) marked $2.90 per share versus a previous $2.66 closing price. 5 days ago The recent performance of TRACON Pharmaceuticals (NASDAQ:TCON) stock in the market spoke loud and clear…